http://www.acc.org/Feed?clinicalTopicID=9cb8eff7-d78e-4dfc-a992-2905830cc91f Clinical Topic Feed: Pulmonary Hypertension and Venous Thromboembolism en /Latest-in-Cardiology/Journal-Scans/2026/08/03/10/06/ADVANCE-OUTCOMES Ralinepag, a selective prostacyclin IP receptor agonist, significantly reduced the risk of first clinical worsening compared with placebo in patients with pulmonary arterial hypertension (PAH) but was associated with more adverse-event-related treatment discontinuations, according to results of the ADVANCE OUTCOMES trial published July 28 in The Lancet. 1785862800000 Articles and Stories /Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! 1785581280000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/29/13/18/eagles-eye-view-29jul2026 In this week’s View, Dr. Eagle looks at a post-hoc analysis of the API-CAT trial that showed recurrent venous thromboembolism (VTE) is uncommon but associated with poor short-term survival of patients with cancer-associated thrombosis. 1785331140000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/07/20/14/38/API-CAT-Analysis Recurrent venous thromboembolism (VTE) is uncommon but associated with poor short-term survival among patients with cancer-associated thrombosis on extended apixaban therapy after at least six months of anticoagulation treatment, according to a post-hoc analysis of the API-CAT trial published July 13 in Circulation. 1784571060000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/08/14/16/eagles-eye-view-08jul2026 In this week’s View, Dr. Eagle looks at withdrawing guideline-directed medical therapy (GDMT) for patients with atrial fibrillation (AF). 1783520220000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/29/15/38/ACC-Scientific-Statement-Addresses-DOACs Even with robust evidence demonstrating their efficacy and safety, direct oral anticoagulants (DOACs) continue to be underused and, at times, inappropriately dosed, particularly in patients at elevated thrombotic risk. 1782828120000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/24/22/05/New-Risk-Score The novel ONCO-DOAC BLEED risk score, developed by Tomoyuki Nagai, MD, et al., provided clinically relevant major bleeding risk stratification for patients with cancer-associated venous thromboembolism (VTE) receiving direct oral anticoagulants (DOAC), according to research published June 16 in JACC: CardioOncology. 1782407460000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/02/12/49/accel-lite-02jun2026 In this interview, Clyde W. Yancy MD, MACC and Mardi Gomberg-Maitland, MD, MSc, FACC discuss the CADENCE Trial (Efficacy And Safety Of Sotatercept In Combined Post-and Pre-capillary Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction). 1780414200000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/06/13/43/eagles-eye-view-06may2026 In this week’s View, Dr. Eagle looks at the NOBLE trial evaluating whether percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) is best for patients with unprotected left main coronary artery disease (CAD). 1778075040000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1777637340000 Articles and Stories